NIH Guide: Weekly Index for October 11, 2024

Funding Opportunities

• Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed)
  (PA-25-121)
  National Cancer Institute
  Application Receipt Date(s): February 05, 2025
• Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed)
  (PA-25-123)
  National Cancer Institute
  Application Receipt Date(s): February 16, 2025
• Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
  (PAR-24-304)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)
  (PAR-25-062)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Multiple dates, see announcement.
• Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
  (PAR-25-098)
  Office of Disease Prevention
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  Office of Research on Women's Health
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Multiple dates, see announcement.
• Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10 Clinical Trial Required)
  (RFA-CA-24-030)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10 Clinical Trial Required)
  (RFA-CA-24-031)
  National Cancer Institute
  Application Receipt Date(s): All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No late applications will be accepted for this Notice of Funding Opportunity (NOFO).
• Single Source: NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network (U10 Clinical Trial Required)
  (RFA-CA-24-032)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1 Clinical Trial Not Allowed)
  (RFA-CA-24-033)
  National Cancer Institute
  Application Receipt Date(s): All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No late applications will be accepted for this Notice of Funding Opportunity (NOFO).
• Single Source: NCI National Clinical Trials Network - Network Radiotherapy and Imaging Core Services Center (U24 Clinical Trial Not Allowed)
  (RFA-CA-24-034)
  National Cancer Institute
  Application Receipt Date(s): All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No late applications will be accepted for this Notice of Funding Opportunity (NOFO).
• NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed)
  (RFA-CA-24-035)
  National Cancer Institute
  Application Receipt Date(s): All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No late applications will be accepted for this Notice of Funding Opportunity (NOFO).
• Human Brain Single-cell Genomics Explorer (U24 - Clinical Trial Not Allowed)
  (RFA-NS-24-038)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): February 14, 2025
• HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional)
  (RFA-NS-25-020)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Cancer Institute
  National Institute on Drug Abuse
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): February 06, 2025
• Occupational Safety and Health Education and Research Centers (T42)
  (RFA-OH-25-002)
  National Institute for Occupational Safety and Health
  Application Receipt Date(s): Multiple dates, see announcement.